These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Radiation synovectomy with 165Dy-FHMA: lymph node uptake and radiation dosimetry calculations. Zalutsky MR; Venkatesan PP; English RJ; Shortkroff S; Sledge CB; Adelstein SJ Int J Nucl Med Biol; 1986; 12(6):457-65. PubMed ID: 3710708 [TBL] [Abstract][Full Text] [Related]
11. [Radiosynovectomy with dysprosium-165 iron hydroxide]. Pirich C; Wanivenhaus A; Graninger W; Kvaternik H; Angelberger P; Pesau B; Havlik E; Flores J; Sinzinger H Acta Med Austriaca; 1993; 20(1-2):49-53. PubMed ID: 8475681 [TBL] [Abstract][Full Text] [Related]
12. From the NIH. Radionuclide therapy for arthritic knees. Doepel LK JAMA; 1985 Feb; 253(6):744-5. PubMed ID: 3968805 [No Abstract] [Full Text] [Related]
13. A comparative study of the safety and efficacy of dysprosium-165 hydroxide macro-aggregate and yttrium-90 silicate colloid in radiation synovectomy--a multicentre double blind clinical trial. Australian Dysprosium Trial Group. Edmonds J; Smart R; Laurent R; Butler P; Brooks P; Hoschl R; Wiseman J; George S; Lovegrove F; Warwick A Br J Rheumatol; 1994 Oct; 33(10):947-53. PubMed ID: 7921756 [TBL] [Abstract][Full Text] [Related]
14. Induction of micronuclei in peripheral blood lymphocytes of patients treated for rheumatoid or osteo-arthritis of the knee with dysprosium-165 hydroxide macroaggregates or yttrium-90 silicate. Prosser JS; Izard BE; Brown JK; Hetherington EL; Lambrecht RM; Cato L; Wallace M; Whitwell J; Wiseman J; Hoschl R Cytobios; 1993; 73(292):7-15. PubMed ID: 8500348 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter. Pirich C; Prüfert U; Havlik E; Schwarmeis E; Flores J; Kvaternik H; Angelberger P; Aiginger J; Wanivenhaus A; Sinzinger H Eur J Nucl Med; 1997 Apr; 24(4):398-402. PubMed ID: 9096090 [TBL] [Abstract][Full Text] [Related]
17. Radiation synovectomy using 165Dy ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis. Pirich C; Pilger A; Schwameis E; Germadnik D; Prüfert U; Havlik E; Lang S; Kvaternik H; Flores JA; Angelberger P; Wanivenhaus A; Rüdiger HW; Sinzinger H J Nucl Med; 2000 Feb; 41(2):250-6. PubMed ID: 10688107 [TBL] [Abstract][Full Text] [Related]
18. MR evaluation of radiation synovectomy of the knee by means of intra-articular injection of holmium-166-chitosan complex in patients with rheumatoid arthritis: results at 4-month follow-up. Lee SH; Suh JS; Kim HS; Lee JD; Song J; Lee SK Korean J Radiol; 2003; 4(3):170-8. PubMed ID: 14530646 [TBL] [Abstract][Full Text] [Related]
19. [166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy. Ferro-Flores G; Hernández-Oviedo O; Arteaga de Murphy C; Tendilla JI; Monroy-Guzmán F; Pedraza-López M; Aldama-Alvarado K Appl Radiat Isot; 2004 Dec; 61(6):1227-33. PubMed ID: 15388114 [TBL] [Abstract][Full Text] [Related]
20. In vivo stability of ferric hydroxide macroaggregates (FHMA). Is it a suitable carrier for radionuclides used in synovectomy? Chinol M; Vallabhajosula S; Zuckerman JD; Goldsmith SJ Int J Rad Appl Instrum B; 1990; 17(5):479-86. PubMed ID: 2391243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]